Clozapine-associated cerebral venous thrombosis

Journal of Clinical Psychopharmacology

Volumn 30, Issue 3, 2010, Pages 335-336

  Srinivasaraju, Ravindra ^a   Reddy, Y C Janardhan ^a   Pal, Pramod K ^a   Math, Suresh Bada ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; FLUPENTIXOL; HEPARIN; OLANZAPINE; PROTEIN C; PROTEIN S; RISPERIDONE; TRIFLUOPERAZINE; TRIHEXYPHENIDYL; VALPROIC ACID;

ADULT; ANTICOAGULANT THERAPY; CASE REPORT; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEMIPARESIS; HUMAN; HYGIENE; INTERNATIONAL NORMALIZED RATIO; IRRITABILITY; LETTER; PARANOID SCHIZOPHRENIA; PARTIAL THROMBOPLASTIN TIME; PHLEBOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT; VOMITING;

ADULT; CLOZAPINE; CRANIAL SINUSES; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS;

EID: 77952366306     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181deb88a     Document Type: Letter

References (17)

1. Lieberman JA. Maximizing clozapine therapy: managing side effects. J Clin Psychiatry. 1998;59(suppl 3):38-43.
2. Hagg S, Spigset O, Soderstrom TG. Association of venous thromboembolism and clozapine. Lancet. 2000;355:1155-1156.
3. Hagg S, Jonsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf. 2009;8:537-547.
4. Werring D, Hacking D, Losseff N, et al. Cerebral venous sinus thrombosis may be associated with clozapine. J Neuropsychiatry Clin Neurosci. 2009;21:343-345.
5. Selten JP, Buller H. Clozapine and venous thromboembolism: further evidence. J Clin Psychiatry. 2003;64:609.
6. Kumaravelu S, Gupta A, Singh K. Cerebral venous thrombosis. Med J Armed Forces India. 2008;64:355-360.
7. Paciullo CA. Evaluating the association between clozapine and venous thromboembolism. Am J Health Syst Pharm. 2008;65:1825-1829.
8. Dietrich-Muszalska A, Rabe-Jablonska J, Nowak P, et al. The first-and second-generation antipsychotic drugs affect ADP-induced platelet aggregation. World J Biol Psychiatry. 2008;19:1-8.
9. Dietrich-Muszalska A, Rabe-Jablonska J, Olas B. The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregation in vitro. World J Biol Psychiatry. 2009;12:1-7.
10. Axelsson S, Hagg S, Eriksson AC, et al. In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation. Clin Exp Pharmacol Physiol. 2007;34:775-780.
11. Anil AE, Ozkan B, Ulusahin A. Venous thromboembolism and clozapine: an association unresolved. Gen Hosp Psychiatry. 2003;25:59-60.
12. Suttmann I, Dittert S, Landgraf R, et al. Clozapine and sudden death. Lancet. 2000;355:842-843; author reply 843.
13. Kose G, Arhan E, Unal B, et al. Valproate-associated coagulopathies in children during short-term treatment. J Child Neurol. 2009;24:1493-1498.
14. Unal O, Deda G, Teber S, et al. Thrombophilic risk factors in epileptic children treated with valproic Acid. Pediatr Neurol. 2009;40:102-106.
15. Banerjea MC, Diener W, Kutschke G, et al. Pro-and anticoagulatory factors under sodium valproate-therapy in children. Neuropediatrics. 2002;33:215-220.
16. Raja M. Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole. Int J Neuropsychopharmacol. 2007;10:107-110.
17. Jong-Yih L. Successful switch from clozapine to aripiprazole: a case report. J Clin Psychopharmacol. 2009;29:93-95.